Armin Amirsadeghi

Armin Amirsadeghi

Auto-generated profile, based on publicly available information

Armin Amirsadeghi

Zernike Institute for Advanced Materials, University of Groningen, Nijenborgh 3, 9747 AG Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
AJArman Jafari
Arman Jafari
AAArmin Amirsadeghi
Armin Amirsadeghi
SHShadi Hassanajili
Shadi Hassanajili
NANegar Azarpira
Negar Azarpira

5 June 2020 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
AAArmin Amirsadeghi
Armin Amirsadeghi
AJArman Jafari
Arman Jafari
LELoek J. Eggermont
Loek J. Eggermont
SHSeyedeh-Sara Hashemi
Seyedeh-Sara Hashemi
SIDI A. BENCHERIFSIDI A. BENCHERIF
SIDI A. BENCHERIF
MKMohammad Khorram
Mohammad Khorram
A number of challenges in skin grafting for wound healing have drawn researchers to focus on skin tissue engineering as an alternative solution. The core idea of tissue engineering is to use scaffolds, cells, and/or bioactive molecules to help the skin to properly recover from injuries. Over the past decades, the field has significantly evolved, developing various strategies to accelerate and improve skin regeneration. However, there are still several concerns that should be addressed. Among these limitations, vascularization is known as a critical challenge that needs thorough consideration. Delayed wound healing of large defects results in an insufficient vascular network and ultimately ischemia. Recent advances in the field of tissue engineering paved the way to improve vascularization of skin substitutes. Broadly, these solutions can be classified into two categories as (1) use of growth factors, reactive oxygen species-inducing nanoparticles, and stem cells to promote angiogenesis, and (2) in vitro or in vivo prevascularization of skin grafts. This review summarizes the state-of-the-art approaches, their limitations, and highlights the latest advances in therapeutic vascularization strategies for skin tissue engineering.

31 May 2023 in Advanced Materials
Verified
Journal Article
Open access
MKMohammad Khoonkari
Mohammad Khoonkari
Julien Es SayedJulien Es Sayed
Julien Es Sayed
MOMarta Oggioni
Marta Oggioni
AAArmin Amirsadeghi
Armin Amirsadeghi
PDPeter Dijkstra
Peter Dijkstra
MKMarleen Kamperman
Marleen Kamperman
3D bioprinting is a powerful fabrication technique in biomedical engineering, which is currently limited by the number of available materials that meet all physicochemical and cytocompatibility requirements for biomaterial inks. Inspired by the key role of coacervation in the extrusion and spinning of many natural materials, hyaluronic acid–chitosan complex coacervates are proposed here as tunable biomaterial inks. Complex coacervates are obtained through an associative liquid–liquid phase separation driven by electrostatic attraction between oppositely charged macromolecules. They offer bioactive properties and facile modulation of their mechanical properties through mild physicochemical changes in the environment, making them attractive for 3D bioprinting. Fine‐tuning the salt concentration, pH, and molecular weight of the constituent polymers results in biomaterial inks that are printable in air and water. The biomaterial ink, initially a viscoelastic fluid, transitions into a viscoelastic solid upon printing due to dehydration (for printing in air) or due to a change in pH and ionic composition (for printing in solution). Consequently, scaffolds printed using the complex coacervate inks are stable without the need for post‐printing processing. Fabricated cell culture scaffolds are cytocompatible and show long‐term topological stability. These results pave the way to a new class of easy‐to‐handle tunable biomaterials for biofabrication.

23 November 2021 in Industrial & Engineering Chemistry Research
Verified
Journal Article
Closed access
SMShahriar Mahdavi
Shahriar Mahdavi
AAArmin Amirsadeghi
Armin Amirsadeghi
AJArman Jafari
Arman Jafari
SNSeyyed Vahid Niknezhad
Seyyed Vahid Niknezhad
SIDI A. BENCHERIFSIDI A. BENCHERIF
SIDI A. BENCHERIF

1 June 2021 in Materials Today Communications
Verified
Journal Article
Open access
AAArmin Amirsadeghi
Armin Amirsadeghi
AJArman Jafari
Arman Jafari
SHSeyedeh-Sara Hashemi
Seyedeh-Sara Hashemi
AKAboozar Kazemi
Aboozar Kazemi
YGYounes Ghasemi
Younes Ghasemi
SNSeyyed Vahid Niknezhad
Seyyed Vahid Niknezhad

12 November 2024 in Advanced Healthcare Materials
Verified
Journal Article
Open access
MGMagdalena Gładysz
Magdalena Gładysz
DUDidi Ubels
Didi Ubels
MKMarcus Koch
Marcus Koch
AAArmin Amirsadeghi
Armin Amirsadeghi
FAFrederique Alleblas
Frederique Alleblas
Małgorzata K. Włodarczyk-BiegunMałgorzata K. Włodarczyk-Biegun
Małgorzata K. Włodarczyk-Biegun
Melt electrowriting (MEW) enables precise scaffold fabrication for biomedical applications. With a limited number of processable materials with short and tunable degradation times, polyhydroxyalkanoates (PHAs) present an interesting option. Here, poly(3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) (PHBV) and a blend of PHBV and poly(3‐hydroxybutyrate‐co‐4‐hydroxybutyrate) (PHBV+P34HB) are successfully melt electrowritten into scaffolds with various architectures. PHBV+P34HB exhibits greater thermal stability, making it a superior printing material compared to PHBV in MEW. The PHBV+P34HB scaffolds subjected to enzymatic degradation show tunable degradation times, governed by enzyme dilution, incubation time, and scaffold surface area. PHBV+P34HB scaffolds seeded with human dermal fibroblasts (HDFs), demonstrate enhanced cell adherence, proliferation, and spreading. The HDFs, when exposed to the enzyme solutions and enzymatic degradation residues, show good viability and proliferation rates. Additionally, HDFs grown on enzymatically pre‐incubated scaffolds do not show any difference in behavior compared those grown on control scaffolds. It is concluded that PHAs, as biobased materials with enzymatically tunable degradability rates, are an important addition to the already limited set of materials available for MEW technology.